| 摘要 |
<p>A therapeutic and/or preventive agent for diabetic ischemic heart disease, characterized in that it comprises, as an active component, a phenylpyridazinone derivative represented by the following general formula (1) or (2): (1) (2) wherein R1 and R2 represent, for example, a hydrogen atom or the like, R3 represents, for example, a hydrogen atom or the like, and R4 represents, for example, a heterocycle, or a salt of the phenylpyridazinone derivative, or a hydrate or solvate thereof.</p> |
